These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 110947)

  • 21. Intravesical therapy comparing BCG, adriamycin, and thiotepa in 200 patients with superficial bladder cancer: a randomized prospective study.
    Martinez-Pineiro JA; Jimenez León J; Martinez-Pineiro L; Fiter L; Mosteiro JA; Navarro J; García Matres MJ; Cárcamo P
    Prog Clin Biol Res; 1989; 310():237-52. PubMed ID: 2505269
    [TBL] [Abstract][Full Text] [Related]  

  • 22. 32p-labeled thio-tepa absorption in normal rat bladders: potential guide for intravesical chemotherapy in bladder cancer.
    Puchner PJ; Veenema RJ; Tomashefsky P; Pinzus T; Tannenbaum T
    Urology; 1974 Jul; 4(1):33-6. PubMed ID: 21322979
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A trial of prophylactic thiotepa or mitomycin C intravesical therapy in patients with recurrent or multiple superficial bladder cancers.
    Flanigan RC; Ellison MF; Butler KM; Gomella LG; McRoberts JW
    J Urol; 1986 Jul; 136(1):35-7. PubMed ID: 3086575
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The use of intravesical thio-tepa in the management of non-invasive carcinoma of the bladder.
    Koontz WW; Prout GR; Smith W; Frable WJ; Minnis JE
    J Urol; 1981 Mar; 125(3):307-12. PubMed ID: 6782251
    [No Abstract]   [Full Text] [Related]  

  • 25. Adjuvant intravesical mitoxantrone versus recombinant interferon-alpha after transurethral resection of superficial bladder cancer: a randomized prospective study.
    Papatsoris AG; Deliveliotis C; Giannopoulos A; Dimopoulos C
    Urol Int; 2004; 72(4):284-91. PubMed ID: 15153724
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The prophylactic use of thio-TEPA in transitional cell carcinoma of the bladder.
    Wescott JW
    J Urol; 1966 Dec; 96(6):913-8. PubMed ID: 4959545
    [No Abstract]   [Full Text] [Related]  

  • 27. Adjuvant chemotherapy of recurrent superficial transitional cell carcinoma: results of a European organization for research on treatment of cancer randomized trial comparing intravesical instillation of thiotepa, doxorubicin and cisplatin. The European Organization for Research on Treatment of Cancer Genitourinary Group.
    Bouffioux C; Denis L; Oosterlinck W; Viggiano G; Vergison B; Keuppens F; De Pauw M; Sylvester R; Cheuvart B
    J Urol; 1992 Aug; 148(2 Pt 1):297-301. PubMed ID: 1635122
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Influence of thiotepa and doxorubicin instillation at time of transurethral surgical treatment of bladder cancer on tumor recurrence: a prospective, randomized, double-blind, controlled trial.
    Zincke H; Utz DC; Taylor WF; Myers RP; Leary FJ
    J Urol; 1983 Mar; 129(3):505-9. PubMed ID: 6403716
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impact of intravesical chemotherapy on recurrence rate of recurrent superficial transitional cell carcinoma of the bladder: results of a meta-analysis.
    Huncharek M; McGarry R; Kupelnick B
    Anticancer Res; 2001; 21(1B):765-9. PubMed ID: 11299841
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long-term intravesical thiotepa treatment in patients with superficial bladder tumors and vesicoureteral reflux.
    Nissenkorn I; Servadio C; Vilikowski E; Glanz I
    J Urol; 1985 Feb; 133(2):198-9. PubMed ID: 3918177
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Single dose intravesical thiotepa as an adjuvant to cystodiathermy in the treatment of transitional cell bladder carcinoma.
    Burnand KG; Boyd PJ; Mayo ME; Shuttleworth KE; Lloyd-Davies RW
    Br J Urol; 1976 Feb; 48(1):55-9. PubMed ID: 817761
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intravesical thiotepa and mitomycin C treatment immediately after transurethral resection and later for superficial (stages Ta and Tis) bladder cancer: a prospective, randomized, stratified study with crossover design.
    Zincke H; Benson RC; Hilton JF; Taylor WF
    J Urol; 1985 Dec; 134(6):1110-4. PubMed ID: 3932685
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Preliminary results of a randomized study between intravesical adriamycin and thio-tepa in the treatment of superficial tumors of bladder].
    Allona Moncada A; Santos García Vaquero I; Polo Villar G; Díaz González R; González Martín M; Zuloaga Gómez A; Martínez Torres JL; Rodríguez Alvarez J; Duarte Vázquez JJ; Megino López JF
    Arch Esp Urol; 1984; 37(2):113-22. PubMed ID: 6431914
    [No Abstract]   [Full Text] [Related]  

  • 34. [Intravesical chemotherapy for superficial bladder tumors].
    Ohmori H
    Gan To Kagaku Ryoho; 1984 Aug; 11(8):1557-62. PubMed ID: 6206797
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intravesical thiotepa versus mitomycin C in patients with Ta, T1 and TIS transitional cell carcinoma of the bladder: a phase III prospective randomized study.
    Heney NM; Koontz WW; Barton B; Soloway M; Trump DL; Hazra T; Weinstein RS
    J Urol; 1988 Dec; 140(6):1390-3. PubMed ID: 3143016
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Dibunol and thio-TEPA treatment of bladder tumors].
    Barsel' VA
    Urol Nefrol (Mosk); 1978; (4):27-30. PubMed ID: 98889
    [No Abstract]   [Full Text] [Related]  

  • 37. Two courses of intravesical bacillus Calmette-Guerin for transitional cell carcinoma of the bladder.
    Haaff EO; Dresner SM; Ratliff TL; Catalona WJ
    J Urol; 1986 Oct; 136(4):820-4. PubMed ID: 3761438
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Intravesical application of thio-tepa for preventing postoperative recurrence of bladder carcinoma].
    Zhang SX; Deng XZ; Tang XD
    Zhonghua Wai Ke Za Zhi; 1986 Aug; 24(8):486-7, 510. PubMed ID: 3102180
    [No Abstract]   [Full Text] [Related]  

  • 39. Intravesical doxorubicin for prophylaxis in the management of recurrent superficial bladder carcinoma.
    Garnick MB; Schade D; Israel M; Maxwell B; Richie JP
    J Urol; 1984 Jan; 131(1):43-6. PubMed ID: 6690745
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The influence of lower urinary tract infection on the recurrence rate of superficial transitional cell carcinoma of the bladder.
    Nissenkorn I; Slutzker D; Schujman E; Servadio C
    J Urol; 1983 Oct; 130(4):674-6. PubMed ID: 6411938
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.